CNMC Investigates GeneraLife Clinics for Failure to Notify Acquisition of Ginemed
The CNMC is investigating GeneraLife Clinics S.L. and its parent company, Investindustrial Growth L.P., for not notifying the acquisition of exclusive control of Ginemed to the CNMC before its execution in August 2021.
04.04.2024 | Portuguese competition authority
GeneraLife Clinics S.L. failed to notify the CNMC of its acquisition of exclusive control of Clínicas Ginemed S.L. before executing it in August 2021, violating the Competition Defense Law. The CNMC has initiated disciplinary proceedings against GeneraLife and its parent company, Investindustrial Growth L.P., for "gun jumping," which is the act of executing a concentration operation without prior notification. The CNMC has required GeneraLife to notify the acquisition, and the investigation is ongoing, with a maximum period of 3 months for resolution by the CNMC.